Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

P3 Health Partners (PIII) Gains from Investment Securities (2019 - 2025)

P3 Health Partners (PIII) has disclosed Gains from Investment Securities for 5 consecutive years, with $14.3 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Gains from Investment Securities changed N/A year-over-year to $14.3 million, compared with a TTM value of $27.0 million through Sep 2025, changed N/A, and an annual FY2024 reading of $103000.0, up 123.79% over the prior year.
  • Gains from Investment Securities was $14.3 million for Q3 2025 at P3 Health Partners, up from -$2.0 million in the prior quarter.
  • Across five years, Gains from Investment Securities topped out at $14.7 million in Q4 2024 and bottomed at -$9.9 million in Q4 2022.
  • Average Gains from Investment Securities over 5 years is $2.3 million, with a median of $319000.0 recorded in 2024.
  • The sharpest move saw Gains from Investment Securities surged 210.56% in 2022, then plummeted 727.59% in 2025.
  • Year by year, Gains from Investment Securities stood at $7.7 million in 2021, then tumbled by 228.7% to -$9.9 million in 2022, then skyrocketed by 92.35% to -$755000.0 in 2023, then surged by 2050.86% to $14.7 million in 2024, then decreased by 3.08% to $14.3 million in 2025.
  • Business Quant data shows Gains from Investment Securities for PIII at $14.3 million in Q3 2025, -$2.0 million in Q2 2025, and $14.7 million in Q4 2024.